Skin Anarchy

Send us Fan MailIn this episode of Skin Anarchy, Dr. Ekta Yadav sits down with branding and marketing strategist Camille Moore to unpack what actually drives growth in today’s beauty industry—and why so many brands get it wrong. In a market saturated with content, Moore challenges one of the most common assumptions: social media is not the brand. It’s only an extension of it.Moore brings a unique perspective shaped by her early work in “unsexy” industries like law, real estate, and medical aesthetics—spaces where demand isn’t built on hype, but on trust and strategy. That foundation allowed her to understand something many founders overlook: if your brand only works when it’s exciting, it doesn’t actually work. The brands that scale are the ones that can create demand regardless of category.A central theme throughout the conversation is alignment. Moore reframes authenticity not as a tone or aesthetic, but as consistency across every touchpoint—product, packaging, messaging, customer experience, and content. When those elements don’t align, consumers don’t question it—they disengage. The strongest brands feel cohesive, not because of one channel, but because everything works together.She also challenges the idea that content should directly sell. Instead, high-performing brands focus on building trust, knowing that conversion follows connection—not pressure. In a real-time, consumer-driven market, relevance comes from listening, adapting, and evolving alongside your audience.This episode offers a clear shift in perspective: brand isn’t built through posts—it’s built through systems.Listen to the full episode to hear Camille Moore break down how modern beauty brands actually grow—and why most are playing the wrong game.Learn more about Third Eye InsightsDon’t forget to subscribe to Skin Anarchy on Apple Podcasts, Spotify, or your preferred platform.Reach out to us through email with any questions.Sign up for our newsletter!Shop all our episodes and products mentioned through our ShopMy Shelf!Support the show

Send us Fan MailIn this special episode, Skin Anarchy is partnering with CEW to shine a spotlight toward a group that rarely receives public recognition in the beauty industry: the scientists behind the products we use every day. Joined by CEW leaders Elana Drell Szyfer and Andrea Nagel, along with award recipients Dr. Jaime Emmetsberger of The Estée Lauder Companies & La Mer and Lavinia Popescu of Olaplex, the conversation explores the vision behind the CEW Innovator Awards and why celebrating scientific talent has become more important than ever.The awards were created to address a long-standing gap in the industry. While founders, executives, and brands often take center stage, the chemists, biologists, and engineers responsible for developing breakthrough ingredients and formulations typically remain behind the scenes. Through its partnership with the New York Society of Cosmetic Chemists, CEW launched the Innovator Awards to recognize women leading scientific progress across research, formulation, sustainability, packaging, and emerging technologies.Throughout the episode, we explore what true innovation in beauty really looks like inside the lab. Jaime discusses how breakthroughs begin with understanding the biology of skin—how cells communicate, how environmental stressors influence aging, and how new tools like artificial intelligence can accelerate discovery without replacing scientific judgment. Meanwhile, Lavinia offers insight into the science of hair repair and how bond-building technologies and emerging peptide research continues to transform modern hair care.Listen to the full episode to hear how these innovators are shaping the future of beauty through science.Learn more about CEW's Innovator AwardsDon’t forget to subscribe to Skin Anarchy on Apple Podcasts, Spotify, or your preferred platform.Reach out to us through email with any questions.Sign up for our newsletter!Shop all our episodes and products mentioned through our ShopMy Shelf!Support the show

Send us Fan MailIn this episode of Skin Anarchy, Dr. Ekta Yadav sits down with Morgan Gordon, VP of Brand Development and Marketing at Salon Perfect and creator of Sliick, for a candid look at what it really takes to build—and sustain—a modern beauty brand. From her early days as a licensed cosmetologist to leading innovation at scale, Morgan brings a rare perspective that bridges professional beauty and retail execution. What emerges quickly is a shift in how beauty brands operate today. The industry no longer moves in predictable cycles—brands are now responding to consumers in real time. Trends evolve within weeks, not seasons, and relevance depends on how closely brands stay connected to what consumers are actually saying, searching, and using. For Morgan, success comes down to translation: turning fast-moving signals into products that meet real needs, without losing quality or execution. The conversation also pulls back the curtain on retail realities. Getting into major retailers is only the beginning—staying there requires constant innovation, operational precision, and the ability to deliver at scale. This becomes even more critical as at-home beauty continues to reshape consumer behavior, creating demand for products that replicate professional results with simplicity and ease.That insight led to the creation of Sliick, a brand built to reimagine at-home waxing by removing friction from the entire experience. Instead of intimidating systems, Sliick focuses on intuitive design, streamlined formulas, and a more approachable user experience.Ultimately, this episode reveals that modern beauty success isn’t about predicting trends—it’s about evolving with the consumer in real time.Listen to the full episode to hear Morgan Gordon break down the mechanics of scaling a beauty brand and staying relevant in today’s fast-moving industry.Shop Sliick & Salon PerfectDon’t forget to subscribe to Skin Anarchy on Apple Podcasts, Spotify, or your preferred platform.Reach out to us through email with any questions.Sign up for our newsletter!Shop all our episodes and products mentioned through our ShopMy Shelf!Support the show

Send us Fan MailIn this episode of Skin Anarchy, Dr. Ekta Yadav sits down with Tom Terranova to explore a side of aesthetic medicine that patients rarely see—but that ultimately determines their safety: infrastructure. While most conversations focus on results, pricing, or provider reputation, this episode shifts the lens to what happens behind the scenes, where clinical protocols, operational systems, and regulatory gaps quietly shape outcomes.Terranova shares the mission behind QUAD A, a nonprofit that has long established safety standards in surgical settings and is now expanding into the rapidly growing med spa space. As aesthetic treatments move further into consumer-driven environments, the industry faces a critical challenge: demand has scaled faster than standardization.One of the most compelling insights from the conversation is the idea that risk in aesthetics is not binary—it’s stratified. Procedures often perceived as “low risk” can vary significantly in complexity and potential for harm. Yet unlike traditional medicine, med spas have lacked a clear framework to define and manage that risk. QUAD A’s tiered approach introduces a more structured way to evaluate procedures, shifting how both providers and patients should think about safety.The discussion also challenges a common assumption: that credentials alone ensure safe care. Terranova emphasizes that true safety depends on more than technical skill—it requires the ability to recognize complications, respond in real time, and operate within a system designed for consistency and accountability. Ultimately, this episode reframes safety as something systemic, not superficial.Listen to the full episode to hear Tom Terranova break down the hidden gaps in aesthetic medicine and what every patient should understand before choosing where to get treated.Learn more about QUAD ADon’t forget to subscribe to Skin Anarchy on Apple Podcasts, Spotify, or your preferred platform.Reach out to us through email with any questions.Sign up for our newsletter!Shop all our episodes and products mentioned through our ShopMy Shelf!Support the show

Send us Fan MailIn this episode of Skin Anarchy, Dr. Ekta Yadav sits down with Dr. Stephanie Culler, co-founder and CEO of Persephone Biosciences, to explore one of the most rapidly evolving frontiers in modern health science: the human microbiome. From early immune development to cancer therapy, the conversation reveals how the trillions of microbes living in our bodies may shape health in ways scientists are only beginning to understand.Dr. Culler’s path into microbiome research began with a personal mission to understand disease after losing both of her grandmothers to cancer. Following her PhD at the California Institute of Technology, where she studied gene therapy approaches to cancer, she moved into industrial biotechnology and microbial engineering. That work eventually led her to co-found Persephone Biosciences, a company focused on translating microbiome science into real-world therapeutics and consumer health solutions.A major focus of the discussion centers on the infant microbiome and its role in shaping immune development. Dr. Culler explains how microbes transferred during birth and nourished through breast milk help “train” the immune system in the earliest stages of life. Yet modern research suggests that key beneficial bacteria—particularly Bifidobacterium infantis—have dramatically declined in Western infants. In large-scale studies conducted by Persephone, only a small percentage of U.S. infants carry adequate levels of this once-dominant microbe.The conversation also explores how microbiome balance may influence responses to cutting-edge cancer treatments like immunotherapy. Emerging research suggests that gut bacteria can significantly affect how patients respond to checkpoint inhibitors, opening the door to microbiome-based interventions that could enhance treatment outcomes.Listen to the full episode to hear Dr. Stephanie Culler explain how microbiome science is transforming our understanding of immunity, disease prevention, and the future of medicine.Learn more about Persephone BiosciencesDon’t forget to subscribe to Skin Anarchy on Apple Podcasts, Spotify, or your preferred platform.Reach out to us through email with any questions.Sign up for our newsletter!Shop all our episodes and products mentioned through our ShopMy Shelf!Support the show

Send us Fan MailIn this episode of Skin Anarchy, Dr. Ekta Yadav sits down with Elana Drell Szyfer, president of Cosmetic Executive Women (CEW) and one of the most influential leaders in the global beauty industry. With more than three decades of experience spanning companies like Chanel, L’Oréal, Avon, Estée Lauder, and RéVive, Elana offers a rare behind-the-scenes look at how careers in beauty evolve—and what it takes to navigate an industry that constantly reinvents itself.Elana's path into beauty was anything but conventional. Originally a history major who imagined a future in nonprofit arts philanthropy, her first role at the Juilliard School focused on connecting donors with scholarship recipients. A shift toward business studies eventually led her into the beauty world through a position at Chanel’s family office. Determined to move closer to the operating side of the industry, she studied trade publications, reached out to industry leaders directly, and ultimately landed at L’Oréal—where her career in beauty truly began.Over the next two decades, Elana built a foundation in marketing leadership across some of the industry’s largest brands. Later, she transitioned into the entrepreneurial side of beauty, leading privately backed companies and guiding brands through transformation, acquisition, and growth—including her tenure as CEO of RéVive. Along the way, she witnessed firsthand how dramatically the beauty landscape has evolved, from traditional advertising and retail counters to today’s fragmented world of social media, influencer discovery, and science-driven storytelling.As she steps into her new role at CEW, Elana reflects on leadership, the future of marketing, and the growing need for clarity around industry buzzwords like biotech and longevity.Listen to the full episode to hear Elana Drell Szyfer share lessons from her career and her vision for the future of the beauty industry.Learn more about CEWDon’t forget to subscribe to Skin Anarchy on Apple Podcasts, Spotify, or your preferred platform.Reach out to us through email with any questions.Sign up for our newsletter!Shop all our episodes and products mentioned through our ShopMy Shelf!Support the show

Send us Fan MailIn this special episode of Skin Anarchy, Dr. Ekta Yadav welcomes back Madhavi Gavini, founder of Droplette—one of the earliest science-forward brands featured on the show. What once felt like a radically different approach to skincare technology now feels increasingly relevant as the industry shifts toward biologics, regenerative ingredients, and delivery science. The conversation revisits Droplette’s origins and explores why effective delivery may be the missing piece in modern skincare innovation.Gavini’s journey into skincare began far outside the beauty industry. With a background in pharmaceutical development, she spent years designing therapies for pediatric diseases, where she encountered one of medicine’s most persistent challenges: delivery. Even when researchers identify the therapeutic molecule that could help treat a condition, getting that molecule into the correct layer of skin is often the hardest part. That realization became the foundation of Droplette’s technology, originally developed alongside MIT-affiliated researchers to enable large molecules to reach skin tissue without needles or barrier injury.The Droplette device generates high-velocity, submicron droplets capable of moving ingredients past the stratum corneum—the skin’s protective outer barrier—allowing molecules far larger than traditional topical ingredients to access viable layers of skin. The implications extend beyond cosmetics, with ongoing collaborations exploring delivery for antibiotics, gene therapies, and other advanced biologics.The episode also dives into the science behind exosomes—one of the most talked-about yet misunderstood areas in regenerative skincare. Gavini explains what exosomes are, why sourcing and stability matter, and why many topical exosome products degrade or fail to penetrate the skin barrier. Double Board-Certified Dermatologist, Dr. Dan Belkin, also shares his clinical perspective on how exosomes are currently used in dermatology and why reliable sourcing, cold-chain handling, and effective delivery systems are essential for maintaining biological activity.Listen to the full episode to hear Madhavi Gavini explain how Droplette is bringing pharmaceutical-grade delivery science into the future of regenerative skincare.Use discount code 'ANARCHY' to get the Exosome Starter Set on subscription for just $349SHOP DROPLETTE1.Quek BL, Srinivas RL, Gavini MP. Droplette: a platform technology to directly deliver nucleic acid therapeutics and other molecules into cells and deep into tissue without transfection reagents. Methods Mol Biol. 2022;2398:211-230. doi:10.1007/978-1-0716-1811-0_14.2.Mahmood A, et al. Droplette—a fluid dynamics-driven platform for transdermal and intracellular delivery of large molecules. FASEB J. 2018;31(S1):924.7.3.Pulakat L, Chen HH, Gavini MP, Ling LA, Tang Y, Mehm A, et al. Transdermal delivery of high molecular weight antibiotics to deep tissue infections via Droplette Micromist Technology Device (DMTD). Pharmaceutics. 2022;14(6):1134*This is a sponsored collaborationSupport the show

Send us Fan MailIn this episode of Skin Anarchy, Dr. Ekta Yadav sits down with beauty industry veteran and product innovator Lorne Lucree to explore an unexpected frontier: allergy care. After decades helping shape iconic brands across L’Oréal, Estée Lauder, and Unilever Prestige, Lucree turned his attention to a category that had remained largely unchanged. What he discovered was striking—while skincare had evolved into a science-driven, barrier-focused discipline, allergy care still relied on reactive treatments designed for symptom suppression rather than biological support. That’s why he created Wizard Wellness.The conversation reframes the nasal cavity not simply as an airway, but as a living barrier system—one with its own microbiome, immune signaling, and protective function, much like the skin. When that barrier becomes disrupted, allergens and pollutants penetrate more easily, triggering inflammation that extends far beyond congestion, affecting sleep, mood, and overall resilience. Instead of approaching allergies as isolated flare-ups, Lucree saw an opportunity to apply principles from microbiome skincare: support the environment itself so the body can defend more effectively.Lucree shares how advances in microbiome science opened the door to a new preventative model—one that focuses on restoring equilibrium rather than sterilizing or suppressing. He also reveals the complexity of formulating for mucosal tissue, where safety, compatibility, and biological precision become paramount.At its core, this episode explores how consumer health categories evolve when science, design, and behavioral insight converge. Listen to the full episode to hear Lorne Lucree explain how barrier biology and microbiome innovation may redefine allergy care—and why the future of wellness begins with protecting the body’s most overlooked interfaces.SHOP WIZARD WELLNESSDon’t forget to subscribe to Skin Anarchy on Apple Podcasts, Spotify, or your preferred platform.Reach out to us through email with any questions.Sign up for our newsletter!Shop all our episodes and products mentioned through our ShopMy Shelf!Support the show

Send us Fan MailIn this episode of Skin Anarchy, Dr. Ekta Yadav sits down with double board-certified dermatologist Dr. Sabrina Fabi to examine how hormonal signaling actively shapes skin resilience, recovery, and structural integrity. This conversation moves beyond trend-driven skincare and into the biology that determines how skin functions at every stage of life.Dr. Fabi emphasizes that skin constantly responds to hormonal shifts. Changes in progesterone, estrogen, testosterone, and neurohormones influence collagen production, barrier strength, inflammation, muscle tone, and healing capacity. Aging reflects signaling patterns — not just the passage of time. When hormones fluctuate, skin behavior changes.A central focus of the discussion is oxytocin. While most people associate oxytocin with bonding and mood, Dr. Fabi explains that skin contains oxytocin receptors that participate in local repair and inflammatory signaling. That neuroendocrine connection reframes how we think about resilience. The brain and skin communicate continuously, and hormonal signaling drives that dialogue.Dr. Fabi applies this signaling-first framework directly through XOMD. Instead of topically applying exogenous hormones, she built XOMD around activating intrinsic pathways that support recovery and tissue strength. The focus remains on optimizing communication within the skin rather than overwhelming it with isolated actives.Throughout the episode, she challenges casual aesthetic culture and reinforces the importance of individualized, long-term planning. Hormones shape anatomy, metabolism, and tissue quality — treatment strategies must reflect that complexity.Listen to the full episode to hear Dr. Sabrina Fabi break down hormonal biology, oxytocin science, and how XOMD advances a more intelligent approach to skin resilience.SHOP XOMD SkincareDon’t forget to subscribe to Skin Anarchy on Apple Podcasts, Spotify, or your preferred platform.Reach out to us through email with any questions.Sign up for our newsletter!Shop all our episodes and products mentioned through our ShopMy Shelf!Support the show

Send us Fan MailIn this special installment of Skin Anarchy’s Lessons in Longevity series, Dr. Ekta Yadav sits down with beauty industry pioneer Melisse Shaban for a conversation that bridges decades of brand leadership with the cutting edge of cellular science. From her early days at Revlon’s counter at Macy’s Herald Square to leading Aveda and The Body Shop — and later founding science-driven ventures like Virtue Labs and Aramore — Shaban has witnessed beauty evolve from aspiration to physiology.But this episode isn’t about nostalgia. It’s about where we’re headed.Together, Dr. Yadav and Shaban unpack how the narrative around aging is shifting. Youth is no longer the sole benchmark of beauty. Instead, vitality, recovery, and cellular performance are redefining the industry. Skincare is moving beyond “hope in a jar” marketing toward biologically grounded innovation — often rooted in research that began in oncology, peptide science, and regenerative medicine labs.A central theme of the conversation is NAD — a molecule essential for cellular energy and mitochondrial function. Rather than attempting to apply NAD topically in ways the skin cannot absorb, Shaban explains how Aramore focuses on supporting the body’s own NAD production through metabolically intelligent pathways. The message is clear: aging begins at the cellular level, and true longevity requires daily metabolic support — not reactive damage control.This episode also tackles accountability in a crowded, hype-driven market. Clinical rigor, mechanistic plausibility, and transparent data are no longer optional — they are the future.Listen to the full episode of Skin Anarchy to hear Melisse Shaban break down cellular energy, NAD science, and why the next era of beauty belongs to longevity-driven innovation grounded in real biology.SHOP ARAMOREDon’t forget to subscribe to Skin Anarchy on Apple Podcasts, Spotify, or your preferred platform.Reach out to us through email with any questions.Sign up for our newsletter!Shop all our episodes and products mentioned through our ShopMy Shelf!*This is a paid collaborationSupport the show